PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 27 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,306 | -99.9% | 2,413,487 | 0.0% | 0.09% | +160.0% |
| Q3 2022 | $2,513,000 | -73.3% | 2,413,487 | -0.0% | 0.04% | -93.1% |
| Q3 2020 | $9,416,000 | +2.9% | 2,414,487 | 0.0% | 0.51% | -34.8% |
| Q2 2020 | $9,151,000 | -19.4% | 2,414,487 | -50.0% | 0.78% | -35.9% |
| Q1 2020 | $11,348,000 | – | 4,828,974 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,413,487 | $2,513,000 | 0.04% |
| CAPITAL PERFORMANCE ADVISORS LLP | 25,974 | $27,000 | 0.02% |
| MEITAV INVESTMENT HOUSE LTD | 244,332 | $256,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,790 | $139,000 | 0.00% |
| IHT Wealth Management, LLC | 22,000 | $23,000 | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
| Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,027 | $3,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| DAVENPORT & Co LLC | 22,000 | $23,000 | 0.00% |